Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|10|3|181-185

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.10, Iss.3, 1999-05, pp. : 181-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Double-Blind, Placebo-Controlled Study of Tacrine in Chinese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 4, 1999-06 ,pp. : 289-294

Karger

Access to resources Recommend Favorite

Circulating Leptin Levels and Weight Loss in Alzheimer’s Disease Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 2, 2001-02 ,pp. : 167-170

Karger

Access to resources Recommend Favorite

Decreased α-Synuclein Serum Levels in Patients with Lewy Body Dementia Compared to Alzheimer’s Disease Patients and Control Subjects

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 6, 2011-07 ,pp. : 413-416

Karger

Access to resources Recommend Favorite

An Open-Label, Multicenter Observational Study for Patients with Alzheimer’s Disease Treated with Memantine in the Clinical Practice

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-01 ,pp. : 10-19

Karger

Access to resources Recommend Favorite

Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 35, Iss. 1-2, 2013-01 ,pp. : 23-33

Karger

Access to resources Recommend Favorite